Studies on metal–organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is an incurable disease, although symptoms are treated with a range of dilator drugs. Despite their clinical benefits, these drugs are limited by systemic side-effects. It is, therefore, increasingly recognised that using controlled drug-release nanoformulation,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed, Nura A., Abou-Saleh, Haissam, Kameno, Yu, Marei, Isra, de Nucci, Gilberto, Ahmetaj-Shala, Blerina, Shala, Fisnik, Kirkby, Nicholas S., Jennings, Lewis, Al-Ansari, Dana E., Davies, Robert P., Lickiss, Paul D., Mitchell, Jane A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900107/
https://www.ncbi.nlm.nih.gov/pubmed/33619326
http://dx.doi.org/10.1038/s41598-021-83423-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900107/
https://www.ncbi.nlm.nih.gov/pubmed/33619326
http://dx.doi.org/10.1038/s41598-021-83423-6

Ejemplares similares